Entera Bio Ltd
NASDAQ:ENTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entera Bio Ltd
NASDAQ:ENTX
|
IL |
|
Apollo Global Management Inc
F:N7I
|
US |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
B
|
BlackRock Inc
F:BLQA
|
US |
|
R
|
Revolution Medicines Inc
F:42Z
|
US |
|
S
|
Secom Co Ltd
DUS:XSC
|
JP |
|
Medallion Financial Corp
NASDAQ:MFIN
|
US |
|
C
|
Copart Inc
F:CO6
|
US |
|
Great Southern Bancorp Inc
NASDAQ:GSBC
|
US |
|
Covivio SA
F:F5D
|
FR |
|
B
|
Barratt Developments P L C
F:3BA
|
UK |
|
T
|
Telefonica SA
F:TNE2
|
ES |
|
Global Education Communities Corp
TSX:GEC
|
CA |
|
Orell Fuessli AG
F:OFH
|
CH |
|
Taskus Inc
F:6VY
|
US |
|
Energy Transfer LP
NYSE:ET
|
US |
|
B
|
British American Tobacco PLC
NYSE:BTI
|
UK |
|
S
|
Secure Energy Services Inc
F:SEP
|
CA |
|
MTN Group Ltd
OTC:MTNOF
|
ZA |
|
A
|
Applied Industrial Technologies Inc
F:AT4
|
US |
Wall St Price Targets
ENTX Price Targets Summary
Entera Bio Ltd
According to Wall Street analysts, the average 1-year price target for
ENTX is 9.18 USD with a low forecast of 9.09 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENTX's stock price target?
Price Target
9.18
USD
According to Wall Street analysts, the average 1-year price target for
ENTX is 9.18 USD with a low forecast of 9.09 USD and a high forecast of 9.45 USD.